{"id":4910,"date":"2024-07-21T09:00:10","date_gmt":"2024-07-21T09:00:10","guid":{"rendered":"https:\/\/regensight.com\/?p=4910"},"modified":"2024-07-21T09:00:12","modified_gmt":"2024-07-21T09:00:12","slug":"argo-clinical-study-published-in-the-prestigious-scientific-journal-ophthalmology","status":"publish","type":"post","link":"https:\/\/regensight.com\/en\/argo-clinical-study-published-in-the-prestigious-scientific-journal-ophthalmology\/","title":{"rendered":"ARGO clinical study published in the prestigious scientific journal Ophthalmology"},"content":{"rendered":"\n<p>\ud83d\udd2c Breakthrough Advancement in Clinical Research for the Treatment of Keratoconus \ud83d\udd2c<\/p>\n\n\n\n<p>We are excited to announce the publication of the <strong>ARGO clinical trial<\/strong> validating <strong>theranostics<\/strong> technology\u00a0 for the precision, predictive and personalized treatment of <strong>keratoconus<\/strong>.<\/p>\n\n\n\n<p>The multicenter clinical study ARGO, conducted in three major universities in Italy (Florence, Messina and Catanzaro), has shown that <strong>theranostic-guided corneal cross-linking<\/strong> offers a revolutionary approach to halt the progression of keratoconus by predicting the outcome at 1 year after treatment with <strong>95% accuracy<\/strong> and<strong> 91% <\/strong>accuracy. This clinical validation marks a significant milestone in advancing the definitive cure of keratoconus.<\/p>\n\n\n\n<p>For further details, read the full study in the most prestigious <a rel=\"noreferrer noopener\" href=\"https:\/\/authors.elsevier.com\/a\/1jRuJamCtQ%7EXN\" target=\"_blank\">scientific journal in Ophthalmology<\/a> (available for free download until September 5, 2024).<\/p>\n\n\n\n<p>With the validation of theranostics for the definitive cure of keratoconus, <strong>Regensight<\/strong> marks the first <em>milestone<\/em> of its development plan that introduces<strong>\u00a0for the first time in<\/strong> the world a transformative technology for the correction of the most disabling visual disorders at all ages.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud83d\udd2c Breakthrough Advancement in Clinical Research for the Treatment of Keratoconus \ud83d\udd2c We are excited to announce the publication of the ARGO clinical trial validating theranostics technology\u00a0 for the precision, predictive and personalized treatment of keratoconus. The multicenter clinical study ARGO, conducted in three major universities in Italy (Florence, Messina and Catanzaro), has shown that [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":4911,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":""},"categories":[35],"tags":[74,70,44],"_links":{"self":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts\/4910"}],"collection":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/comments?post=4910"}],"version-history":[{"count":1,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts\/4910\/revisions"}],"predecessor-version":[{"id":4913,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts\/4910\/revisions\/4913"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/media\/4911"}],"wp:attachment":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/media?parent=4910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/categories?post=4910"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/tags?post=4910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}